An interventional study of A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass and Intradural Adhesion Lysis in Syringomyelia and Spinal Cord Injury, sponsored by Xuanwu Hospital, Beijing. Active, not recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Xuanwu Hospital, Beijing · Not applicable, Interventional, and Treatment
Yuan C, Zhang C, Wang J, Wu H, Chen Z, Jian F, Guan J. A novel minimally invasive surgical technique for posttraumatic syringomyelia: subarachnoid-subarachnoid…PubMed 39983113 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 80 studies in Spinal Cord Injuries with a site in China — 26 open to participants now, 32 under way, none of them phase 3. Spinal Cord Injuries · China.
Among the 80 studies in Spinal Cord Injuries with a site in China, this one is the 16th largest by enrollment of the 71 interventional ones that give a count, is one of 13 that started in 2025, is one of 44 with no phase, reaches primary completion later than 20 of the 31 other live ones, and was the 47th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →26 of the 80 studies in Spinal Cord Injuries with a site in China are open now. Recruiting first, the newest first:
BCIFlex Medical Technology Co., Ltd. · Sites in China
Ages 18–65
NeuroXess Technology (shanghai) Co.,Ltd. · Sites in China
Ages 18–65
Shengjing Hospital · Sites in China
Ages 18–80
Zhongda Hospital · Sites in China
Ages 18–75
Shanghai StairMed Technology Co., Ltd. · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
80 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 16 · Phase 2 17 · Phase 3 2 · Phase 4 1
First in 2000; this study’s year is marked. 13 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 80 is above the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 36 across the 71 interventional studies, 107 across the 9 observational. Of the 23 that completed or were terminated, 3 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 80 have an industry lead sponsor. The 10 most frequent:
Xuanwu Hospital, Beijing is the lead sponsor of 365 studies on the registry; 231 are open to participants now.
Xuanwu Hospital, Beijing has 6 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
15 of the studies in Spinal Cord Injuries with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07900490Hainan UniversityRecovery and Safety After Epidural Spinal Cord Stimulation in People With Spinal Cord Injury | 2026-11-30 |
| NCT06436716Affiliated 2 Hospital of Nantong UniversityArtificial Intelligence Model for Traumatic Cervical Spinal Cord Injury Based on Radiomics and Genomics | 2026-12 |
| NCT07207798Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEpidural Electrical Stimulation in Spinal Cord Injury (T11-L3) | 2026-12-30 |
| NCT07907952Beijing Tsinghua Chang Gung HospitaltSCS Combined With Rehabilitation Training in Treating Paraplegic Patients After SCI | 2026-12-31 |
| NCT07105878Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEpidural Electrical Stimulation in Spinal Cord Injury | 2026-12-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 80 studies in Spinal Cord Injuries with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To determine whether A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass results in better patient outcomes with improved quality of life and fewer complications compared to intradural adhesion lysis in individuals with posttraumatic Syringomyelia.
Recently, our team was the first to report in the Journal of Neurosurgery: Spine (JNSSPINE) a minimally invasive subarachnoid-subarachnoid cerebrospinal fluid bypass technique for the treatment of post-traumatic syringomyelia. This novel approach has attracted considerable international attention and achieved favorable clinical outcomes for the treatment of post-traumatic syringomyelia. To establish high-level evidence, participants with posttraumatic Syringomyelia will be randomized to either have A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass or intradural adhesion Lysis. The participant will then return to the neurosurgeon's office at the following time points which are consistent with standard of care practice: 3-6, 12±2months. At these visits, the clinician will complete a physical exam and the participant will report on the prognosis of symptoms and complete questionnaires. A spine MRI will be performed 3-6, 12±2months after the surgery.
The multicenter design, target sample size, assessor masking, eligibility criteria, and outcome hierarchy described in this record were specified in the ethics-approved protocol before enrollment of the first participant. The initial public registry entry did not fully reflect the finalized protocol. The registry record was corrected on 2026-11, before database lock and before any unblinded between-group analysis, to align it with the prospectively approved protocol.
The criteria were revised on the registry on Nov 10, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
After dissections of the normal arachnoid mater at the cephalic and caudal sites, 2 tubes made of medical grade silicone (internal diameter 1.1 mm, external diameter 2.5 mm; Sophysa Systems Corp.) were inserted into the cephalic and caudal ends of the normal subarachnoid space. The tubes were only inserted into the normal subarachnoid space, with the remaining portions running subcutaneously.
Procedure: A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass
The dura is opened sharply, exposing the spinal cord. After microsurgical dissection adhesion, the dura is sewn closed with a dural graft.
Procedure: Intradural Adhesion Lysis
After dissections of the normal dura mater at the cranial and caudal sites, a tunneling device (a passer) was used to create a subcutaneous tunnel. Two tubes made of medical grade silicone (internal diameter 1.1 mm, external diameter 2.5 mm; Sophysa Systems Corp.) were inserted into the cranial and caudal ends of the normal subarachnoid space. Under the surgical microscope, the normal dura was incised bilaterally approximately 3 mm on either side of the midline at the cranial end. The arachnoid was opened, with the proximal ends of the drainage tubes inserted approximately 5 cm into the normal subarachnoid space, with the remaining portions running subcutaneously. No loosening operations were performed at the site of injury. The incisions were sutured layer by layer
Intradural spinal cord Adhesion Lysis
The Number of Patients With Clinical Improvement
Number of patients who experienced improvement in clinical or neurological symptoms-such as; sensory dysfunction (numbness, paresthesia, or sensory loss), neuropathic pain, motor weakness, gait impairment, bowel and bladder dysfunction, and spasticity.
Time frame: 3-6, 12±2 months
change of the volume of syrinx,
defined as change in length, maximal cross-sectional diameter, or both.
Time frame: 3-6, 12±2 months
Klekamp and Sammi syringomyelia scale
for evaluating the spinal cord function, Each item is scored on a scale from 0 to 5, with 5 representing the best possible functional status.
Time frame: 3-6, 12±2 months
modified Japanese Orthopaedic Association Scores (mJOA)
Motor function, sensory, bladder function;for evaluating the spinal cord function;0-17, higher scores mean a better outcome
Time frame: 3-6, 12±2 months
xuanwu syringomyelia scale
for evaluating the spinal cord function, for evaluating the spinal cord function;0-18, higher scores mean a worse outcome
Time frame: 3-6, 12±2 months
complication
various complication, such as fever, csf fistula
Time frame: 3-6, 12±2 months
ASIA score
American Spinal Injury Association(ASIA) Score for evaluating the spinal cord function, degree of the spinal cord function, motor1-100, sensory 1-224, higher scores mean a better outcome
Time frame: 3-6, 12±2 months
VAS score
VAS Score for evaluating the degree of the pain, VAS 0-10, higher scores mean a worse outcome
Time frame: 3-6, 12±2 months
Plan to share: Undecided
Started Jun 2025 (actual). Primary completion is estimated for Jun 2027, 24 months after the start.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 24 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Apr 2024 → Jun 2025, primary completion Apr 2025 → Jun 2027 and completion Apr 2027 → Jun 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Yuan C, Zhang C, Wang J, Wu H, Chen Z, Jian F, Guan J. A novel minimally invasive surgical technique for posttraumatic syringomyelia: subarachnoid-subarachnoid…PubMed 39983113 ↗
Yuan C, Zhang C, Wang J, Wu H, Chen Z, Jian F, Guan J. A novel minimally invasive surgical technique for posttraumatic syringomyelia: subarachnoid-subarachnoid…PubMed 39983113 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.